# Japanese Physicians’ Views on Drug Post-Marketing Surveillance

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/japanese-physicians-views-on-drug-post-marketing-surveillance/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kazuki Maeda,Rumi Katashima,Keisuke Ishizawa,Hiroaki Yanagawa |
| Citations | 11 |
| DOI | 10.14740/jocmr2328w |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.jocmr.org/index.php/JOCMR/article/download/2328/1301 |
| OpenAlex ID | https://openalex.org/W1800693533 |
| PMID | 26566409 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Rumi Katashima](https://scholariq.org/researchers/rumi-katashima/)

## Paper primary topic

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)

## Paper topics

- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Pharmaceutical industry and healthcare](https://scholariq.org/topics/pharmaceutical-industry-and-healthcare/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.